GlassScriptPhysician profile
Nathan Hung Ho
NPI 1841220845
$18,553.53
in general payments reported to CMS, 2019-2025
35 companies · $4,095 in 2025
The $4,095 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,512 · 2020: $968 · 2021: $1,074 · 2022: $1,072 · 2023: $1,693 · 2024: $6,139 · 2025: $4,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,454 · Travel and Lodging: $3,390 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,453.74 |
| Travel and Lodging | $3,389.75 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,312.01 | 2019-2025 | Aveir, Optis, Gallant |
| Boston Scientific Corporation | $5,661.29 | 2019-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Rhythmia Mapping System |
| Medtronic, INC. | $2,361.19 | 2021-2025 | Corevalve Evolut R |
| Shockwave Medical, INC | $1,221.53 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $375.57 | 2019-2024 | Orsiro Mission |
| Abiomed | $360.86 | 2020-2025 | Impella |
| Biosense Webster, INC. | $326.73 | 2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $238.21 | 2019-2023 | Xarelto |
| Elutia, INC. | $214.59 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $127.24 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $122.20 | 2019-2025 | |
| Philips North America LLC | $111.58 | 2019-2021 | |
| Pfizer INC. | $102.07 | 2019-2025 | |
| Cvrx, INC. | $100.75 | 2020 | |
| Edwards Lifesciences Corporation | $99.47 | 2020-2025 | Sapien 3 Ultra Resilia |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $92.53 | 2021-2023 | Guideliner, Manta, Vascband |
| Chiesi USA, INC. | $83.64 | 2024 | Kengreal |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $78.67 | 2019 | |
| W. L. Gore & Associates, INC. | $63.96 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $58.90 | 2019-2020 | |
| Cardiovascular Systems INC. | $57.03 | 2021-2022 | |
| Amgen INC. | $49.63 | 2019-2024 | Repatha |
| Regeneron Healthcare Solutions, INC. | $44.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.11 | 2022-2023 | |
| Heartflow, INC. | $37.39 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.31 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.68 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $22.39 | 2024 | |
| Cook Medical LLC | $21.54 | 2024 | Zilver Ptx |
| Terumo Medical Corporation | $20.60 | 2019 | |
| Bardy Diagnostics, INC. | $20.00 | 2021 | |
| Irhythm Technologies, INC. | $18.37 | 2022 | |
| Lundbeck LLC | $18.22 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $13.86 | 2023 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.